Patterns of somatic mutation in human cancer genomes
Top Cited Papers
- 8 March 2007
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 446 (7132) , 153-158
- https://doi.org/10.1038/nature05610
Abstract
Cancers arise owing to mutations in a subset of genes that confer growth advantage. The availability of the human genome sequence led us to propose that systematic resequencing of cancer genomes for mutations would lead to the discovery of many additional cancer genes. Here we report more than 1,000 somatic mutations found in 274 megabases (Mb) of DNA corresponding to the coding exons of 518 protein kinase genes in 210 diverse human cancers. There was substantial variation in the number and pattern of mutations in individual cancers reflecting different exposures, DNA repair defects and cellular origins. Most somatic mutations are likely to be ‘passengers’ that do not contribute to oncogenesis. However, there was evidence for ‘driver’ mutations contributing to the development of the cancers studied in approximately 120 genes. Systematic sequencing of cancer genomes therefore reveals the evolutionary diversity of cancers and implicates a larger repertoire of cancer genes than previously anticipated.Keywords
This publication has 40 references indexed in Scilit:
- The Consensus Coding Sequences of Human Breast and Colorectal CancersScience, 2006
- Statistical Analysis of Pathogenicity of Somatic Mutations in CancerGenetics, 2006
- Nuclear Titin interacts with A- and B-type lamins in vitro and in vivoJournal of Cell Science, 2006
- A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancerNature Genetics, 2005
- The PANTHER database of protein families, subfamilies, functions and pathwaysNucleic Acids Research, 2004
- Targeted cancer therapyNature, 2004
- A census of human cancer genesNature Reviews Cancer, 2004
- Mutational Analysis of the Tyrosine Kinome in Colorectal CancersScience, 2003
- Mutations of the BRAF gene in human cancerNature, 2002
- Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite InstabilityScience, 1995